BCRP/ABCG2 Inhibitors

DBCAT002662Pharmacologic class

A DrugBank category of 198 drugs. 170 of them are approved.

Also known as
BCRP Inhibitor · BCRP inhibitors · BCRP/ABCG2-Inhibitors · Breast Cancer Resistance Protein Inhibitors

What you can answer from here — as of June 29, 2021

198DrugsEach linked to its full drug card
Sign in
626Drug targetsEvery drug–target pair in the class, with bond type
Sign in
25,949Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
38Routes of administrationHow the drugs in this class are given
Sign in

Which targets do BCRP/ABCG2 Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account